Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2021-08-27 00:00:00 ET · period of report 2021-08-27 · accession 0001209191-21-053642 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-27 | 2021-08-27 | KYMR | Chesworth Richard | CSO | M - OptEx | $20.00 | +33.8K | 33.8K | New | +$675.6K |
| D | 2021-08-27 | 2021-08-27 | KYMR | Chesworth Richard | CSO | S - Sale+OE | $60.12 | -33.8K | 0 | -100% | -$2.03M |
| D | 2021-08-27 | 2021-08-27 | KYMR | Chesworth Richard | CSO | M - OptEx | $0.00 | -33.8K | 263.3K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-27 | M | A | 33,779 | $20.00 | 33,779 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-27 | S | D | 33,779 | $60.12 | 0 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.99 to $60.69. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-08-27 | M | D | 33,779 | $0.00 | 263,340 | D | $20.00 · — to 2030-08-19 | 33,779 Common Stock | (F3) Twenty-five percent (25%) of the shares subject to this option vested and became exercisable on August 17, 2021, and the remainder of the shares shall vest in equal monthly installments for a period of thirty-six (36) months thereafter. |